Published in Lab Business Week, April 29th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at MIV Therapeutics.
Report 1: MIV Therapeutics Inc. (MIVT), a developer of next-generation biocompatible polymer-free drug-eluting stents and advanced drug delivery systems, has announced two recent financings totaling $4 million to accelerate the company's ongoing development of next generation stents and to support recent acquisition activity.
MIVT recently ratified and completed a private placement for an aggregate amount of $4 million pursuant to the terms and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week